LungLifeAI achieves faster cancer diagnosis with AI & ML| Persistent Systems

Persistent’s AI algorithm accelerates LungLifeAI’s mission to transform cancer diagnosis

LungLifeAI uses machine learning and artificial intelligence to reduce analysis time by nearly 70%.

Challenges

LunglifeAI wanted to increase precision to reduce high false positives rates and reduce missed CTCs in other classes. Additionally, the wanted to reduce the extensive manual observation required which resulted in a high cost and time consuming analysis.

Solutions

LungLifeAI, a pioneer in LiquidBiopsy® technology, uses machine learning and artificial intelligence to enable life-saving early diagnosis of lung cancer. Persistent’s AI algorithms have reduced analysis time by nearly 70% thereby accelerating LungLife’s efforts to greatly reduce the impact of a disease that claims around 400 lives per day.

Impact of the solution solution delivered by Persistent

70%

Reduction in Analysis time

62%

Reduction in false detections

72%

Overall Improvement

Outcomes

The solution enabled LungLifeAI to reduce analysis time by nearly 70% and realize a reduction of 62% in the number of falsely detected CTCs. Additionally, LungLifeAI was able to achieve 94% recall across the cases, showing an improvement over 72.9%.

Technologies Used

Life Sciences Innovation & Engineering
Custom image annotation using open source Python libraries
Deep learning model using open source Python Libraries TensorFlow/Keras
OpenCV

Contact us

(*) Asterisk denotes mandatory fields

First name*

Last name*

Company*

Job title*

Work email*

Phone number (optional)

You can also email us directly at info@persistent.com